long-term epidemiological data absent Metabolic effects potential impacts on glucose metabolism, insulin sensitivity, and lipid profiles inadequately characterized in long-term studies Endocrine disruption effects on other hormonal axes with chronic use not well-studied Regulatory & Competitive Sport Status FDA Position Neither CJC-1295 nor Ipamorelin has received FDA approval for any human therapeutic indication: Investigational New Drug status available only for qualified research applications 2024 FDA compounding restrictions both peptides temporarily placed on Category 2 list (substances presenting significant safety risks), later removed pending further review Not approved for human use in any formulation or indication Warning letters issued to companies marketing peptides for human therapeutic use Compounding status uncertain as of 2024-2025, regulatory position on compounding pharmacy access remains in flux The FDA has specifically cited cardiovascular safety concerns, immunogenicity risks, and lack of adequate safety and efficacy data as bases for restricting access outside formal research contexts
Examples include: brussels sprouts, broccoli, kale, cauliflower, mustard greens, watercress Studies suggest that diets rich in cruciferous vegetables are associated with healthy antioxidant activity in the body
It is a peptide rather than a testosterone-based steroid, so on its own it does not need a PCT, though any steroid base you stack it with will
Oxidative stress triggers inflammation in the body, which puts you at higher risk for DNA damage and those chronic diseases already mentioned
Most documented protocols treat glutathione supplementation as a maintenance intervention rather than a cycled compound
Pairing a GHRH analog with a ghrelin mimetic is a recurring theme in the literature, and it is also why blended research compounds exist, such as the tesamorelin and ipamorelin blend studied as a single preparation
.png)
